On September 4, 2020, COSON Co., Ltd. (KOSDAQ:A069110) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,120 KRW | +0.99% |
|
+7.39% | -28.08% |
07-04 | Genexine, Inc. Appoints Jaehyun Choi as Head of R&D | CI |
06-26 | Genexine, Inc. signed a letter of intent to acquire EPD Biotherapeutics Inc. for KRW25.6 billion. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.08% | 214M | |
+20.63% | 127B | |
+23.21% | 117B | |
+25.39% | 27.67B | |
-20.17% | 20.33B | |
-17.05% | 16.79B | |
-18.07% | 15.63B | |
+11.92% | 14.84B | |
-47.70% | 14.65B | |
+58.32% | 14.43B |
- Stock Market
- Equities
- A095700 Stock
- News Genexine, Inc.
- COSON Co., Ltd. announced that it has received KRW 10 billion in funding from Progen Co. Ltd., Genexine, Inc.